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background: It is reported that Percutaneous Coronary Intervention (PCI) on moderate lesions (60% - 90% stenosis on angiogram) of cardiac 
allograft vasculopathy may incite heightened immune response resulting in greater disease in intervened arteries as well as arteries that were not 
intervened. It is not known whether medical therapy (MRx) alone will maintain patency of these lesions and avoid such response.
Methods: Between 1994 and 2012 we evaluated 29 heart transplant patients who developed 60% - 90% stenosis in a non-left main (nLM), non-
proximal left anterior descending artery (nPLAD) vessel. Patients were divided into PCI vs. MRx groups. At 1 year follow up, primary (moderate lesion) 
and secondary (other vessels) lesions were assessed for worsening, defined as ≥ 50% restenosis in stented vessel and ≥ 30% worsening of stenosis 
on other vessels. Left Ventricular Ejection Fraction (LVEF) by echocardiography was also compared at baseline and 1 year later.
results: 10 patients underwent PCI and 19 were kept on MRx alone. There was no difference in primary lesion worsening. More patients in the PCI 
group developed secondary lesion worsening compared to the MRx group (70% vs. 21% respectively, p = 0.02, see table). There was no difference in 
LVEF between the two groups.
PCI (n=10) MRx (n=19)
Primary Lesion Average % Stenosis (74 ± 8)% (63 ± 5)%
Mean Follow up Period (years) 1.1 ± 0.4 1.2 ± 0.3
Primary Lesion Worsening (≥ 50% restenosis in PCI group or ≥ 30% worsening of stenosis in MRx group) 2/10 (20%) 5/19 (26%)
Secondary Lesion Worsening (≥ 30% worsening of stenosis from baseline) 7/10 (70%) 4/19 (21%)
Baseline LVEF (56 ± 9)% (57 ± 4)%
Follow up LVEF (56 ± 9)% (59 ± 4)%
conclusions: PCI of nLM/nPLAD moderate lesions (60% - 90%) appears to incite heightened immune response with worsening stenosis in vessels 
that were not intervened. MRx may be a better choice to avoid this response. A randomized trial is warranted.
